AdaptHealth (AHCO) Stock Price Target 2026

The average analyst price target for AdaptHealth is $10.38, 41.2% above the current price. Of 7 analysts, 7 rate it Buy. Targets range from $8 to $16. The latest change came on Nov 5, 2026, when Leerink Partners raised its price target on AdaptHealth from $7 to $8 and kept an Outperform rating.

The Average Analyst Price Target for AdaptHealth is $10.38.

Price Target Range — 11 Quarters

Analyst Consensus — 7 Analysts

7Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$10.38Upside to Avg. PT+41.2%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for AdaptHealth Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Leerink Partners	Whit Mayo	PT Raise	Outperform	$7→$8
Nov 4, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$10→$9
Sep 17, 2026	Baird	Eric Coldwell	PT Cut	Outperform	$10→$9
Aug 6, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$14→$10
Aug 6, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$15→$8
Aug 5, 2026	Truist Securities	David Macdonald	PT Cut	Buy	$14→$9
Jul 21, 2026	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$11→$13
Jul 6, 2026	Baird	Eric Coldwell	PT Cut	Outperform	$18→$15
May 11, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$13→$15
May 6, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$14→$16
May 6, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$15→$14
Apr 13, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$13→$14
Feb 26, 2026	Leerink Partners	Whit Mayo	PT Cut	Outperform	$13→$12
Nov 6, 2025	Canaccord Genuity	Richard Close	PT Raise	Buy	$14→$15
May 12, 2025	Truist Securities	David Macdonald	PT Cut	Buy	$14→$13
May 8, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$14→$13
Feb 27, 2025	Baird	Eric Coldwell	PT Raise	Outperform	$14→$16
Feb 26, 2025	Canaccord Genuity	Richard Close	PT Raise	Buy	$13→$14
Feb 26, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$11→$14
Feb 26, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$12→$14